Physiological  ||| S:0 E:14 ||| JJ
measurements  ||| S:14 E:27 ||| NNS
and  ||| S:27 E:31 ||| CC
prevalence  ||| S:31 E:42 ||| NN
of  ||| S:42 E:45 ||| IN
lower  ||| S:45 E:51 ||| JJR
airway  ||| S:51 E:58 ||| NN
diseases  ||| S:58 E:67 ||| NNS
in  ||| S:67 E:70 ||| IN
Trotters  ||| S:70 E:79 ||| NNP
with  ||| S:79 E:84 ||| IN
dorsal  ||| S:84 E:91 ||| JJ
displacement  ||| S:91 E:104 ||| NN
of  ||| S:104 E:107 ||| IN
the  ||| S:107 E:111 ||| DT
soft  ||| S:111 E:116 ||| JJ
palate  ||| S:116 E:123 ||| JJ
Dorsal  ||| S:123 E:130 ||| JJ
displacement  ||| S:130 E:143 ||| NN
of  ||| S:143 E:146 ||| IN
the  ||| S:146 E:150 ||| DT
soft  ||| S:150 E:155 ||| JJ
palate  ||| S:155 E:162 ||| NNS
( ||| S:162 E:163 ||| -LRB-
DDSP ||| S:163 E:167 ||| NNP
)  ||| S:167 E:169 ||| -RRB-
is  ||| S:169 E:172 ||| VBZ
one  ||| S:172 E:176 ||| CD
of  ||| S:176 E:179 ||| IN
the  ||| S:179 E:183 ||| DT
most  ||| S:183 E:188 ||| RBS
common  ||| S:188 E:195 ||| JJ
obstructive  ||| S:195 E:207 ||| JJ
conditions  ||| S:207 E:218 ||| NNS
of  ||| S:218 E:221 ||| IN
the  ||| S:221 E:225 ||| DT
upper  ||| S:225 E:231 ||| JJ
respiratory  ||| S:231 E:243 ||| JJ
tract  ||| S:243 E:249 ||| NN
in  ||| S:249 E:252 ||| IN
the  ||| S:252 E:256 ||| DT
racehorse ||| S:256 E:265 ||| NN
.  ||| S:265 E:267 ||| .
This  ||| S:267 E:272 ||| DT
condition  ||| S:272 E:282 ||| NN
has  ||| S:282 E:286 ||| VBZ
a  ||| S:286 E:288 ||| DT
complex  ||| S:288 E:296 ||| JJ
aetiology  ||| S:296 E:306 ||| NN
which  ||| S:306 E:312 ||| WDT
may  ||| S:312 E:316 ||| MD
be  ||| S:316 E:319 ||| VB
caused  ||| S:319 E:326 ||| VBN
or  ||| S:326 E:329 ||| CC
exacerbated  ||| S:329 E:341 ||| VBN
by  ||| S:341 E:344 ||| IN
pharyngeal  ||| S:344 E:355 ||| JJ
inflammation ||| S:355 E:367 ||| NN
.  ||| S:367 E:369 ||| .
Additionally ||| S:369 E:381 ||| RB
,  ||| S:381 E:383 ||| ,
lower  ||| S:383 E:389 ||| JJR
respiratory  ||| S:389 E:401 ||| JJ
airway  ||| S:401 E:408 ||| NN
diseases  ||| S:408 E:417 ||| NNS
may  ||| S:417 E:421 ||| MD
be  ||| S:421 E:424 ||| VB
associated  ||| S:424 E:435 ||| VBN
with  ||| S:435 E:440 ||| IN
DDSP  ||| S:440 E:445 ||| NNP
thereby  ||| S:445 E:453 ||| RB
contributing  ||| S:453 E:466 ||| VBG
to  ||| S:466 E:469 ||| TO
exercise  ||| S:469 E:478 ||| VB
intolerance  ||| S:478 E:490 ||| VBN
in  ||| S:490 E:493 ||| IN
these  ||| S:493 E:499 ||| DT
horses ||| S:499 E:505 ||| NNS
.  ||| S:505 E:507 ||| .
The  ||| S:507 E:511 ||| DT
aim  ||| S:511 E:515 ||| NN
of  ||| S:515 E:518 ||| IN
this  ||| S:518 E:523 ||| DT
study  ||| S:523 E:529 ||| NN
was  ||| S:529 E:533 ||| VBD
to  ||| S:533 E:536 ||| TO
measure  ||| S:536 E:544 ||| VB
physiological  ||| S:544 E:558 ||| JJ
variables  ||| S:558 E:568 ||| NNS
during  ||| S:568 E:575 ||| IN
a  ||| S:575 E:577 ||| DT
standardised  ||| S:577 E:590 ||| JJ
exercise  ||| S:590 E:599 ||| NN
test  ||| S:599 E:604 ||| NN
and  ||| S:604 E:608 ||| CC
to  ||| S:608 E:611 ||| TO
assess  ||| S:611 E:618 ||| VB
the  ||| S:618 E:622 ||| DT
prevalence  ||| S:622 E:633 ||| NN
and  ||| S:633 E:637 ||| CC
consequences  ||| S:637 E:650 ||| NNS
of  ||| S:650 E:653 ||| IN
lower  ||| S:653 E:659 ||| JJR
respiratory  ||| S:659 E:671 ||| JJ
airway  ||| S:671 E:678 ||| JJ
disease  ||| S:678 E:686 ||| NN
in  ||| S:686 E:689 ||| IN
horses  ||| S:689 E:696 ||| NNS
with  ||| S:696 E:701 ||| IN
DDSP ||| S:701 E:705 ||| NNP
.  ||| S:705 E:707 ||| .
A  ||| S:707 E:709 ||| DT
total  ||| S:709 E:715 ||| NN
of  ||| S:715 E:718 ||| IN
46  ||| S:718 E:721 ||| CD
horses  ||| S:721 E:728 ||| NNS
were  ||| S:728 E:733 ||| VBD
included  ||| S:733 E:742 ||| VBN
in  ||| S:742 E:745 ||| IN
this  ||| S:745 E:750 ||| DT
study ||| S:750 E:755 ||| NN
:  ||| S:755 E:757 ||| :
22  ||| S:757 E:760 ||| CD
in  ||| S:760 E:763 ||| IN
the  ||| S:763 E:767 ||| DT
control  ||| S:767 E:775 ||| NN
and  ||| S:775 E:779 ||| CC
24  ||| S:779 E:782 ||| CD
in  ||| S:782 E:785 ||| IN
the  ||| S:785 E:789 ||| DT
DDSP  ||| S:789 E:794 ||| NNP
groups ||| S:794 E:800 ||| NNS
.  ||| S:800 E:802 ||| .
All  ||| S:802 E:806 ||| DT
horses  ||| S:806 E:813 ||| NNS
performed  ||| S:813 E:823 ||| VBD
a  ||| S:823 E:825 ||| DT
SET  ||| S:825 E:829 ||| NNP
with  ||| S:829 E:834 ||| IN
measurement  ||| S:834 E:846 ||| NN
of  ||| S:846 E:849 ||| IN
heart  ||| S:849 E:855 ||| NN
rate  ||| S:855 E:860 ||| NN
( ||| S:860 E:861 ||| -LRB-
HR ||| S:861 E:863 ||| NNP
)  ||| S:863 E:865 ||| -RRB-
and  ||| S:865 E:869 ||| CC
blood  ||| S:869 E:875 ||| NN
lactate  ||| S:875 E:883 ||| NN
concentration ||| S:883 E:896 ||| NN
.  ||| S:896 E:898 ||| .
One  ||| S:898 E:902 ||| CD
hour  ||| S:902 E:907 ||| NN
post  ||| S:907 E:912 ||| NN
exercise ||| S:912 E:920 ||| NN
,  ||| S:920 E:922 ||| ,
respiratory  ||| S:922 E:934 ||| JJ
samples  ||| S:934 E:942 ||| NNS
were  ||| S:942 E:947 ||| VBD
collected  ||| S:947 E:957 ||| VBN
for  ||| S:957 E:961 ||| IN
cytological  ||| S:961 E:973 ||| NN
and  ||| S:973 E:977 ||| CC
bacteriological  ||| S:977 E:993 ||| JJ
analysis ||| S:993 E:1001 ||| NN
.  ||| S:1001 E:1003 ||| .
During  ||| S:1003 E:1010 ||| IN
exercise ||| S:1010 E:1018 ||| NN
,  ||| S:1018 E:1020 ||| ,
the  ||| S:1020 E:1024 ||| DT
DDSP  ||| S:1024 E:1029 ||| NNP
group  ||| S:1029 E:1035 ||| NN
had  ||| S:1035 E:1039 ||| VBD
higher  ||| S:1039 E:1046 ||| JJR
blood  ||| S:1046 E:1052 ||| NN
lactate  ||| S:1052 E:1060 ||| NN
concentration  ||| S:1060 E:1074 ||| NN
than  ||| S:1074 E:1079 ||| IN
the  ||| S:1079 E:1083 ||| DT
control  ||| S:1083 E:1091 ||| NN
group ||| S:1091 E:1096 ||| NN
.  ||| S:1096 E:1098 ||| .
According  ||| S:1098 E:1108 ||| VBG
to  ||| S:1108 E:1111 ||| TO
BAL  ||| S:1111 E:1115 ||| NNP
results ||| S:1115 E:1122 ||| NNS
,  ||| S:1122 E:1124 ||| ,
50  ||| S:1124 E:1127 ||| CD
and  ||| S:1127 E:1131 ||| CC
63 ||| S:1131 E:1133 ||| CD
%  ||| S:1133 E:1135 ||| NN
of  ||| S:1135 E:1138 ||| IN
control  ||| S:1138 E:1146 ||| NN
and  ||| S:1146 E:1150 ||| CC
DDSP  ||| S:1150 E:1155 ||| NNP
group  ||| S:1155 E:1161 ||| NN
horses ||| S:1161 E:1167 ||| NNS
,  ||| S:1167 E:1169 ||| ,
respectively ||| S:1169 E:1181 ||| RB
,  ||| S:1181 E:1183 ||| ,
had  ||| S:1183 E:1187 ||| VBD
evidence  ||| S:1187 E:1196 ||| NN
of  ||| S:1196 E:1199 ||| IN
inflammatory  ||| S:1199 E:1212 ||| JJ
airway  ||| S:1212 E:1219 ||| JJ
disease  ||| S:1219 E:1227 ||| NN
( ||| S:1227 E:1228 ||| -LRB-
IAD ||| S:1228 E:1231 ||| NNP
) ||| S:1231 E:1232 ||| -RRB-
.  ||| S:1232 E:1234 ||| .
In  ||| S:1234 E:1237 ||| IN
the  ||| S:1237 E:1241 ||| DT
DDSP  ||| S:1241 E:1246 ||| NNP
group ||| S:1246 E:1251 ||| NN
,  ||| S:1251 E:1253 ||| ,
42 ||| S:1253 E:1255 ||| CD
%  ||| S:1255 E:1257 ||| NN
of  ||| S:1257 E:1260 ||| IN
horses  ||| S:1260 E:1267 ||| NNS
had  ||| S:1267 E:1271 ||| VBD
a  ||| S:1271 E:1273 ||| DT
syndrome  ||| S:1273 E:1282 ||| NN
of  ||| S:1282 E:1285 ||| IN
tracheal  ||| S:1285 E:1294 ||| JJ
inflammation  ||| S:1294 E:1307 ||| NNS
( ||| S:1307 E:1308 ||| -LRB-
STI ||| S:1308 E:1311 ||| NNP
)  ||| S:1311 E:1313 ||| -RRB-
with  ||| S:1313 E:1318 ||| IN
71 ||| S:1318 E:1320 ||| CD
%  ||| S:1320 E:1322 ||| NN
of  ||| S:1322 E:1325 ||| IN
this  ||| S:1325 E:1330 ||| DT
group  ||| S:1330 E:1336 ||| NN
having  ||| S:1336 E:1343 ||| VBG
bacteria  ||| S:1343 E:1352 ||| NNS
isolated  ||| S:1352 E:1361 ||| VBN
at  ||| S:1361 E:1364 ||| IN
> ||| S:1364 E:1365 ||| CD
10 ||| S:1365 E:1367 ||| CD
( ||| S:1367 E:1368 ||| -LRB-
5 ||| S:1368 E:1369 ||| LS
)  ||| S:1369 E:1371 ||| -RRB-
CFU ||| S:1371 E:1374 ||| NNP
/ ||| S:1374 E:1375 ||| NNP
ml ||| S:1375 E:1377 ||| NN
.  ||| S:1377 E:1379 ||| .
Horses  ||| S:1379 E:1386 ||| NNS
with  ||| S:1386 E:1391 ||| IN
DDSP  ||| S:1391 E:1396 ||| NNP
showed  ||| S:1396 E:1403 ||| VBD
evidence  ||| S:1403 E:1412 ||| NN
of  ||| S:1412 E:1415 ||| IN
a  ||| S:1415 E:1417 ||| DT
high  ||| S:1417 E:1422 ||| JJ
prevalence  ||| S:1422 E:1433 ||| NN
of  ||| S:1433 E:1436 ||| IN
IAD  ||| S:1436 E:1440 ||| NNP
and  ||| S:1440 E:1444 ||| CC
STI  ||| S:1444 E:1448 ||| NNP
with  ||| S:1448 E:1453 ||| IN
an  ||| S:1453 E:1456 ||| DT
associated  ||| S:1456 E:1467 ||| JJ
positive  ||| S:1467 E:1476 ||| JJ
bacteriology  ||| S:1476 E:1489 ||| NN
in  ||| S:1489 E:1492 ||| IN
55 ||| S:1492 E:1494 ||| CD
%  ||| S:1494 E:1496 ||| NN
of  ||| S:1496 E:1499 ||| IN
the  ||| S:1499 E:1503 ||| DT
cases ||| S:1503 E:1508 ||| NNS
.  ||| S:1508 E:1510 ||| .
Even  ||| S:1510 E:1515 ||| RB
if  ||| S:1515 E:1518 ||| IN
DDSP  ||| S:1518 E:1523 ||| NNP
is  ||| S:1523 E:1526 ||| VBZ
treated  ||| S:1526 E:1534 ||| VBN
by  ||| S:1534 E:1537 ||| IN
surgery ||| S:1537 E:1544 ||| NN
,  ||| S:1544 E:1546 ||| ,
the  ||| S:1546 E:1550 ||| DT
authors ||| S:1550 E:1557 ||| NNS
'  ||| S:1557 E:1559 ||| POS
recommendation  ||| S:1559 E:1574 ||| NN
would  ||| S:1574 E:1580 ||| MD
be  ||| S:1580 E:1583 ||| VB
to  ||| S:1583 E:1586 ||| TO
investigate  ||| S:1586 E:1598 ||| VB
the  ||| S:1598 E:1602 ||| DT
possibility  ||| S:1602 E:1614 ||| NN
of  ||| S:1614 E:1617 ||| IN
lower  ||| S:1617 E:1623 ||| JJR
respiratory  ||| S:1623 E:1635 ||| JJ
airway  ||| S:1635 E:1642 ||| NN
problems  ||| S:1642 E:1651 ||| NNS
which  ||| S:1651 E:1657 ||| WDT
may  ||| S:1657 E:1661 ||| MD
also  ||| S:1661 E:1666 ||| RB
be  ||| S:1666 E:1669 ||| VB
impacting  ||| S:1669 E:1679 ||| VBN
the  ||| S:1679 E:1683 ||| DT
horse ||| S:1683 E:1688 ||| NN
's  ||| S:1688 E:1691 ||| POS
performance  ||| S:1691 E:1703 ||| NN
and ||| S:1703 E:1706 ||| CC
/ ||| S:1706 E:1707 ||| NNP
or  ||| S:1707 E:1710 ||| CC
surgery  ||| S:1710 E:1718 ||| NN
efficiency ||| S:1718 E:1728 ||| NN
.  ||| S:1728 E:1730 ||| .
